STING1 and neoplasm: Indeed, the production of cytokines like IL-6 is regulated by non-canonical NF-κB signaling; moreover, this pathway likely disrupts conventional STING–TBK1–IFN signaling, thus suggesting that STING activation may have both anti- and pro-tumor effects, depending on transient states of the evolving tumor [75].